The Ministry of Health of the Government of National Unity has issued a directive prohibiting the circulation of a specific cancer drug in the Libyan market.
The ministry addressed its directive to the Medical Supply Authority, the International Oversight Department, and directors of hospitals and private medical centers, instructing them not to distribute the drug “Lonsurf” due to its lack of the active ingredient necessary for cancer treatment.
According to the directive, the drug is counterfeit and is only legally distributed through the official local representative, as it is currently being circulated illegally.
The ministry has called for immediate action to prevent its distribution and urged all relevant entities to report and withdraw the product to ensure patient safety, emphasizing the importance of monitoring medications post-market.
Health
